Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center

• Asıl Yazarlar: Mahendra Munirathnam (Yazar), R Kishore (Yazar), S N Sanjana (Yazar), R Archita (Yazar), C N Mohan (Yazar), Preethi Rajeshwari Gandhi (Yazar), Manjushree Mohan (Yazar), Bhahuddin Mulla (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Introduction: The catastrophic effects of corona in 2020 identified the use of broad-spectrum antiviral remdesivir (RDV). The beneficial effects of RDV are not proven and documented in many trials in COVID. Materials and Methods: Reverse transcriptase-polymerase chain reaction (RT-PCR)-confirmed coh...